006620 — DongKoo Bio & Pharma Co Balance Sheet
0.000.00%
Last trade - 00:00HealthcareAdventurousSmall CapContrarian
- KR₩146bn
- KR₩155bn
- KR₩195bn
- 99
- 51
- 10
- 55
Annual balance sheet for DongKoo Bio & Pharma Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 21,694 | 32,666 | 29,507 | 31,956 | 34,785 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 22,034 | 20,681 | 17,592 | 16,408 | 19,403 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 58,806 | 71,901 | 72,353 | 73,832 | 87,417 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 31,787 | 38,489 | 40,377 | 40,051 | 39,681 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 104,279 | 132,725 | 144,353 | 154,786 | 172,059 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 28,615 | 38,345 | 40,508 | 50,022 | 66,044 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 32,181 | 47,073 | 49,701 | 54,662 | 69,953 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 72,098 | 85,652 | 94,653 | 100,124 | 102,106 |
| Total Liabilities & Shareholders' Equity | 104,279 | 132,725 | 144,353 | 154,786 | 172,059 |
| Total Common Shares Outstanding |